Article info

Download PDFPDF

Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors

Authors

  1. Correspondence to Dr James J DiNicolantonio; jjdinicol{at}gmail.com
View Full Text

Citation

DiNicolantonio JJ, Barroso-Aranda J, McCarty MF
Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors

Publication history

  • Accepted April 7, 2021
  • First published April 19, 2021.
Online issue publication 
April 19, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.